» Articles » PMID: 12124266

Extreme Pathway Analysis of Human Red Blood Cell Metabolism

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2002 Jul 19
PMID 12124266
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The development of high-throughput technologies and the resulting large-scale data sets have necessitated a systems approach to the analysis of metabolic networks. One way to approach the issue of complex metabolic function is through the calculation and interpretation of extreme pathways. Extreme pathways are a mathematically defined set of generating vectors that describe the conical steady-state solution space for flux distributions through an entire metabolic network. Herein, the extreme pathways of the well-characterized human red blood cell metabolic network were calculated and interpreted in a biochemical and physiological context. These extreme pathways were divided into groups based on such criteria as their cofactor and by-product production, and carbon inputs including those that 1) convert glucose to pyruvate; 2) interchange pyruvate and lactate; 3) produce 2,3-diphosphoglycerate that binds to hemoglobin; 4) convert inosine to pyruvate; 5) induce a change in the total adenosine pool; and 6) dissipate ATP. Additionally, results from a full kinetic model of red blood cell metabolism were predicted based solely on an interpretation of the extreme pathway structure. The extreme pathways for the red blood cell thus give a concise representation of red blood cell metabolism and a way to interpret its metabolic physiology.

Citing Articles

Genome-scale models in human metabologenomics.

Mardinoglu A, Palsson B Nat Rev Genet. 2024; 26(2):123-140.

PMID: 39300314 DOI: 10.1038/s41576-024-00768-0.


Biological and genetic determinants of glycolysis: Phosphofructokinase isoforms boost energy status of stored red blood cells and transfusion outcomes.

Nemkov T, Stephenson D, Earley E, Keele G, Hay A, Key A Cell Metab. 2024; 36(9):1979-1997.e13.

PMID: 38964323 PMC: 11374506. DOI: 10.1016/j.cmet.2024.06.007.


Proteomes of plasmodium knowlesi early and late ring-stage parasites and infected host erythrocytes.

Anderson D, Peterson M, Lapp S, Galinski M J Proteomics. 2024; 302:105197.

PMID: 38759952 PMC: 11357705. DOI: 10.1016/j.jprot.2024.105197.


How the 'Aerobic/Anaerobic Glycolysis' Meme Formed a 'Habit of Mind' Which Impedes Progress in the Field of Brain Energy Metabolism.

Schurr A Int J Mol Sci. 2024; 25(3).

PMID: 38338711 PMC: 10855259. DOI: 10.3390/ijms25031433.


The role of CD47 in non-neoplastic diseases.

Wang C, Feng Y, Patel D, Xie H, Lv Y, Zhao H Heliyon. 2023; 9(12):e22905.

PMID: 38125492 PMC: 10731077. DOI: 10.1016/j.heliyon.2023.e22905.


References
1.
Schuster S, Fell D, Dandekar T . A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks. Nat Biotechnol. 2000; 18(3):326-32. DOI: 10.1038/73786. View

2.
Mulquiney P, Kuchel P . Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: computer simulation and metabolic control analysis. Biochem J. 1999; 342 Pt 3:597-604. PMC: 1220500. View

3.
Schilling C, Palsson B . Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J Theor Biol. 2000; 203(3):249-83. DOI: 10.1006/jtbi.2000.1088. View

4.
Ouzounis C, Karp P . Global properties of the metabolic map of Escherichia coli. Genome Res. 2000; 10(4):568-76. PMC: 310896. DOI: 10.1101/gr.10.4.568. View

5.
Palsson B . The challenges of in silico biology. Nat Biotechnol. 2000; 18(11):1147-50. DOI: 10.1038/81125. View